Cited by 312

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

microRNA‐101 is a potent inhibitor of autophagy

Frankel, Lisa B, Wen, Jiayu, Lees, Michael, Høyer‐Hansen, Maria, Farkas, Thomas, Krogh, Anders, Jäättelä, Marja, Lund, Anders H·2011·The EMBO Journal

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emboj.2011.331

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 75

  1. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A (2007) Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 14: 500–510 · DOI
  2. Alexa A, Rahnenfuhrer J, Lengauer T (2006) Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600–1607 · DOI
  3. Alli E, Yang JM, Ford JM, Hait WN (2007a) Reversal of stathmin‐mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol 71: 1233–1240 · DOI
  4. Alli E, Yang JM, Hait WN (2007b) Silencing of stathmin induces tumor‐suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 26: 1003–1012 · DOI
  5. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas‐Tikhonenko A, Thompson CB (2007) Autophagy inhibition enhances therapy‐induced apoptosis in a Myc‐induced model of lymphoma. J Clin Invest 117: 326–336 · DOI
  6. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE (2005) Regulation by let‐7 and lin‐4 miRNAs results in target mRNA degradation. Cell 122: 553–563 · DOI
  7. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin‐induced cell death. J Cell Biol 171: 603–614 · DOI · Paper page
  8. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83–92 · DOI
  9. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M (1992) The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70: 715–728 · DOI
  10. Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, Flaegstad T, Einvik C (2011) Tumour‐suppressor microRNAs let‐7 and mir‐101 target the proto‐oncogene MYCN and inhibit cell proliferation in MYCN‐amplified neuroblastoma. Br J Cancer 105: 296–303 · DOI
  11. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down‐regulation of micro‐RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524–15529 · DOI · Paper page
  12. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999–3004 · DOI
  13. Cassimeris L (2002) The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 14: 18–24 · DOI
  14. Chen N, Debnath J (2010) Autophagy and tumorigenesis. FEBS Lett 584: 1427–1435 · DOI
  15. Chen N, Karantza V (2011) Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11: 157–168 · DOI
  16. Chiang CW, Huang Y, Leong KW, Chen LC, Chen HC, Chen SJ, Chou CK (2010) PKCalpha mediated induction of miR‐101 in human hepatoma HepG2 cells. J Biomed Sci 17: 35 · DOI
  17. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, Pilpel Y, Nielsen FC, Oren M, Lund AH (2010) p53‐independent upregulation of miR‐34a during oncogene‐induced senescence represses MYC. Cell Death Differ 17: 236–245 · DOI · Paper page
  18. Corcelle EA, Puustinen P, Jaattela M (2009) Apoptosis and autophagy: Targeting autophagy signalling in cancer cells – ‘trick or treats’? FEBS J 276: 6084–6096 · DOI
  19. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM (2006) Pre‐B cell proliferation and lymphoblastic leukemia/high‐grade lymphoma in E(mu)‐miR155 transgenic mice. Proc Natl Acad Sci USA 103: 7024–7029 · DOI
  20. Croizet‐Berger K, Daumerie C, Couvreur M, Courtoy PJ, van den Hove MF (2002) The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production. Proc Natl Acad Sci USA 99: 8277–8282 · DOI
  21. de Medina P, Payre B, Boubekeur N, Bertrand‐Michel J, Terce F, Silvente‐Poirot S, Poirot M (2009) Ligands of the antiestrogen‐binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ 16: 1372–1384 · DOI · Paper page
  22. Deangelis JT, Li Y, Mitchell N, Wilson L, Kim H, Tollefsbol T (2010) 2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells. J Proteome Res 10: 447–458 · DOI
  23. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, White E (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51–64 · DOI
  24. Farkas T, Hoyer‐Hansen M, Jaattela M (2009) Identification of novel autophagy regulators by a luciferase‐based assay for the kinetics of autophagic flux. Autophagy 5: 1018–1025 · DOI
  25. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post‐transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102–114 · DOI
  26. Fukui K, Tamura S, Wada A, Kamada Y, Igura T, Kiso S, Hayashi N (2007) Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatol Res 37: 957–965 · DOI
  27. Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S (2005) Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York, NY, USA: Springer Science and Business Media Inc. · DOI
  28. Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, Enright AJ, Schier AF (2006) Zebrafish MiR‐430 promotes deadenylation and clearance of maternal mRNAs. Science 312: 75–79 · DOI · Paper page
  29. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH (2010) MicroRNA‐145 targets YES and STAT1 in colon cancer cells. PLoS One 5: e8836 · DOI
  30. Grimson A, Farh KK, Johnston WK, Garrett‐Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91–105 · DOI · Paper page
  31. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835–840 · DOI · Paper page
  32. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110: 177–189 · DOI
  33. He L, Thomson JM, Hemann MT, Hernando‐Monge E, Mu D, Goodson S, Powers S, Cordon‐Cardo C, Lowe SW, Hannon GJ, Hammond SM (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828–833 · DOI
  34. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta‐analysis. Bioinformatics 22: 2825–2827 · DOI
  35. Hoyer‐Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R, Mathiasen IS, Jaattela M (2007) Control of macroautophagy by calcium, calmodulin‐dependent kinase kinase‐beta, and Bcl‐2. Mol Cell 25: 193–205 · DOI · Paper page
  36. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96–104 · DOI · Paper page
  37. Iancu C, Mistry SJ, Arkin S, Atweh GF (2000) Taxol and anti‐stathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res 60: 3537–3541
  38. Iorio MV, Croce CM (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848–5856 · DOI
  39. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065–7070 · DOI · Paper page
  40. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL (2004) Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117: 4837–4848 · DOI
  41. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419–427 · DOI
  42. Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584: 1287–1295 · DOI · Paper page
  43. Karantza‐Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, White E (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21: 1621–1635 · DOI
  44. Katayama M, Kawaguchi T, Berger MS, Pieper RO (2007) DNA damaging agent‐induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14: 548–558 · DOI
  45. Kaushal GP, Kaushal V, Herzog C, Yang C (2008) Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy 4: 710–712 · DOI
  46. Kent OA, Chivukula RR, Mullendore M, Wentzel EA, Feldmann G, Lee KH, Liu S, Leach SD, Maitra A, Mendell JT (2010) Repression of the miR‐143/145 cluster by oncogenic Ras initiates a tumor‐promoting feed‐forward pathway. Genes Dev 24: 2754–2759 · DOI
  47. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY (2008) miR‐19, miR‐101 and miR‐130 co‐regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 11: 1137–1139 · DOI
  48. Li M, Hou Y, Wang J, Chen X, Shao ZM, Yin XM (2011) Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem 286: 7327–7338 · DOI
  49. Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, Sun Z, Wei L, Zheng X (2009) MicroRNA‐101 regulates expression of the v‐fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 49: 1194–1202 · DOI
  50. Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, Yuan J (2010) Genome‐wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci USA 107: 14164–14169 · DOI · Paper page
  51. Lu J, Getz G, Miska EA, Alvarez‐Saavedra E, Lamb J, Peck D, Sweet‐Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838 · DOI
  52. Marino G, Fernandez AF, Cabrera S, Lundberg YW, Cabanillas R, Rodriguez F, Salvador‐Montoliu N, Vega JA, Germana A, Fueyo A, Freije JM, Lopez‐Otin C (2010) Autophagy is essential for mouse sense of balance. J Clin Invest 120: 2331–2344 · DOI
  53. Marino G, Salvador‐Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopez‐Otin C (2007) Tissue‐specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin‐3. J Biol Chem 282: 18573–18583 · DOI
  54. Marino G, Uria JA, Puente XS, Quesada V, Bordallo J, Lopez‐Otin C (2003) Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem 278: 3671–3678 · DOI
  55. Marklund U, Larsson N, Gradin HM, Brattsand G, Gullberg M (1996) Oncoprotein 18 is a phosphorylation‐responsive regulator of microtubule dynamics. EMBO J 15: 5290–5298 · DOI
  56. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, Shimizu S (2009) Discovery of Atg5/Atg7‐independent alternative macroautophagy. Nature 461: 654–658 · DOI · Paper page
  57. Phadke AP, Jay CM, Wang Z, Chen S, Liu S, Haddock C, Kumar P, Pappen BO, Rao DD, Templeton NS, Daniels EQ, Webb C, Monsma D, Scott S, Dylewski D, Frieboes HB, Brunicardi FC, Senzer N, Maples PB, Nemunaitis J et al (2011) In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human stathmin 1 oncoprotein. DNA Cell Biol (advance online publication; doi:10.1089) · DOI
  58. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, Gorski SM (2008) Macroautophagy inhibition sensitizes tamoxifen‐resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112: 389–403 · DOI · Paper page
  59. Rana S, Maples PB, Senzer N, Nemunaitis J (2008) Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther 8: 1461–1470 · DOI
  60. Ravikumar B, Imarisio S, Sarkar S, O'Kane CJ, Rubinsztein DC (2008) Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci 121: 1649–1660 · DOI
  61. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa‐Kobayashi S, Thompson CB, Tsujimoto Y (2004) Role of Bcl‐2 family proteins in a non‐apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6: 1221–1228 · DOI · Paper page
  62. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, Breuhahn K (2007) Protumorigenic overexpression of stathmin/Op18 by gain‐of‐function mutation in p53 in human hepatocarcinogenesis. Hepatology 46: 759–768 · DOI
  63. Sobel A (1991) Stathmin: a relay phosphoprotein for multiple signal transduction? Trends Biochem Sci 16: 301–305 · DOI
  64. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V (2009) MiR‐101 downregulation is involved in cyclooxygenase‐2 overexpression in human colon cancer cells. Exp Cell Res 315: 1439–1447 · DOI
  65. Stuart‐Harris R, Davis A (2010) Optimal adjuvant endocrine therapy for early breast cancer. Womens Health (Lond Engl) 6: 383–398 · DOI
  66. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM (2009) MicroRNA‐101, down‐regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135–1142 · DOI
  67. Szyniarowski P, Corcelle‐Termeau E, Farkas T, Hoyer‐Hansen M, Nylandsted J, Kallunki T, Jaattela M (2011) A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditions. Autophagy 7: 892–903 · DOI · Paper page
  68. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH, Han B, Tan P, Kumar‐Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM (2008) Genomic loss of microRNA‐101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695–1699 · DOI
  69. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F (2010) MicroRNA‐101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285: 18344–18351 · DOI
  70. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257–2261 · DOI · Paper page
  71. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ (2010) MicroRNA‐101 is down‐regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46: 2295–2303 · DOI
  72. Wu L, Fan J, Belasco JG (2006) MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103: 4034–4039 · DOI
  73. Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo YY, Mao H, Hao C, Olson JJ, Curran WJ, Wang Y (2010) Targeting DNA‐PKcs and ATM with miR‐101 sensitizes tumors to radiation. PLoS One 5: e11397 · DOI
  74. Yu L, Hui‐chen F, Chen Y, Zou R, Yan S, Chun‐xiang L, Wu‐ru W, Li P (1999) Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential. Clin Exp Metastasis 17: 213–219 · DOI
  75. Zhao Z, Liu XF, Wu HC, Zou SB, Wang JY, Ni PH, Chen XH, Fan QS (2010) Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1‐related epidermal growth factor signaling pathway. Cancer Sci 101: 1454–1462 · DOI

Cited by

Sorted by citations

See all 312

Metadata

Authors
Frankel, L. B., Wen, J., Lees, M., Høyer‐Hansen, M., Farkas, T., Krogh, A., Jäättelä, M., & Lund, A. H.
Venue
The EMBO Journal
Published
2011-09-13
Volume
30
Issue
22
Pages
4628-4641
ISSN
  • 0261-4189
  • 1460-2075
Cited by
312
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review